Ardelyx (FRA:41X) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:41X Ardelyx Inc FRA:41X
69 GF Score
Price €3.34
GF Value €7.79
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Ardelyx Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:41X vs IMTX, TRAX, AVLN: Short Percentage of Float Comparison

For the Biotechnology subindustry, Ardelyx's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ardelyx Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ardelyx's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Ardelyx's Short Percentage of Float falls into.


FRA:41X
69GF Score
Ardelyx Inc FRA:41X
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ardelyx (FRA:41X) Overvalued in 2026?

Based on GuruFocus' analysis, Ardelyx stock appears to be undervalued. The current stock price of €3.34 is trading 57.1% below its estimated GF Value™ of €7.79. GuruFocus considers Ardelyx to be Possible Value Trap.

Key valuation signals for FRA:41X:

  • Short Percentage of Float:
  • GF Value™: €7.79 vs. price of €3.34 (57.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the FRA:41X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ardelyx Business Description

Address 400 Fifth Avenue, Suite 210, Waltham, MA, USA, 02451
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
69GF Score

Get the complete analysis for FRA:41X

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.34
Price
€7.79
GF Value